Thursday, September 4, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Insights on Aris Water Solutions Recent Ratings and Price Targets

Elaine Mendonca by Elaine Mendonca
March 11, 2024
in Breaking News
0
Finance_Fiscal (3)
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Aris Water Solutions (NYSE: ARIS) has been under the microscope of analysts in recent months, with a range of opinions shaping their assessments. Let’s delve into the latest analyst insights:

– Total Ratings: 3 Positive, 1 Neutral
– Last 30 Days: 1 Positive
– 1 Month Ago: 1 Positive, 1 Neutral
– 12-Month Price Targets: Average $13.62, High $15.00, Low $11.00

Recent Analyst Actions and Price Targets:

– John Mackay from Goldman Sachs upgraded the rating to Buy with a target price of $14.50
– Praneeth Satish from Wells Fargo adjusted the rating to Equal-Weight with a target price of $11.00
– Spiro Dounis from Citigroup raised the rating to Buy with a target price of $14.00
– Jeff Campbell from Seaport Global issued a Buy rating with a target price of $15.00

Insights on Analyst Ratings:

Analysts are constantly reassessing their recommendations in response to market dynamics and company performance, adapting to the latest developments surrounding Aris Water Solutions.

For a more comprehensive analysis of Aris Water Solutions analyst ratings, consider consulting financial resources such as Yahoo Finance, MarketBeat, Barron’s, Benzinga, and Stock Analysis.

ARIS Stock Shows Strong Performance Near 52-Week High and Above 200-Day Moving Average

On March 11, 2024, ARIS stock showed strong performance as it traded near the top of its 52-week range and above its 200-day simple moving average. This indicated a positive trend in the stock’s performance and potentially signaled bullish sentiment among investors.

The price of ARIS shares increased by $0.20 since the market last closed, representing a 1.67% rise in value. The stock opened at $11.99, inline with its previous close, suggesting stability in the stock’s price movement.

Investors may have been encouraged by ARIS’s strong performance, leading to increased buying activity and driving up the stock’s price. The fact that the stock was trading near its 52-week high and above its 200-day moving average could have further bolstered investor confidence in ARIS’s potential for growth.

ARIS Stock Reports Impressive Financial Performance in 2024: Revenue, Net Income, and EPS on the Rise

On March 11, 2024, ARIS stock showed significant improvements in its financial performance compared to the previous year and the last quarter. According to data from CNN Money, the total revenue for ARIS stood at $392.12 million for the past year, marking a 22.15% increase from the previous year. In the last quarter, the total revenue was $104.12 million, showing a 4.35% increase from the previous quarter.

The net income for ARIS was reported at $18.89 million for the past year, reflecting an impressive 1011.06% increase from the previous year. However, the net income held flat at $5.40 million for the last quarter. Earnings per share (EPS) for ARIS were $0.59 for the past year, showing a remarkable 1306.43% increase from the previous year. The EPS held flat at $0.17 for the last quarter.

Overall, ARIS stock showed strong financial performance with significant increases in total revenue, net income, and EPS compared to the previous year. Investors may view these positive financial indicators as a sign of the company’s growth potential and may consider investing in ARIS stock. However, the flat net income and EPS for the last quarter may raise some concerns among investors.

Tags: ARIS
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Logistics Stock Market Today (2)

Anticipating CryoPorts Earnings Report Analysis and Expectations

Pickleball sports

Anticipated Earnings Report for Manchester United Analyzing Past Performance and Future Expectations

Finance analyst

Analyst Reiterates Market Perform Rating on Enhabit with Revised Price Target

Recommended

Corbus Stock

Corbus Shares Advance as Pipeline Progress Takes Center Stage

22 hours ago
Finance_ projections

Navigating Market Volatility The Role of Circuit Breakers in Financial Stability

2 years ago
Finances

Enhabit NYSE EHAB Earnings Report Preview and Analysis

2 years ago
S&P Global Stock

S&P Global Stock: Mixed Signals Amid Leadership Shift

1 month ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba AMD AMZN Apple BA Broadcom C Coca-Cola Coinbase COST CRWD DIS Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSFT NIO Nvidia Opendoor Oracle Palantir PayPal Pepsi PLTR Red Cat Robinhood Rocket Lab USA Salesforce SMCI Strategy Tesla Tilray TSLA Unitedhealth Wolfspeed
No Result
View All Result

Highlights

Procter & Gamble Navigates a Costly Tariff Landscape

Legal Challenges Emerge for PetIQ Following Its Transition to Private Ownership

Nextdoor Stock Faces Divergent Views Amid Strategic Shift

Petco Shares Plummet Amid Escalating Class Action Pressure

National Healthcare Shares Face Pivotal Technical Battle

Roche Completes Landmark Acquisition of Biotech Innovator Poseida Therapeutics

Trending

Douglas Dynamics Stock
Analysis

Douglas Dynamics Stock Surges on Upgraded Forecasts and Record Performance

by Felix Baarz
September 4, 2025
0

A bullish industry outlook from Zacks Equity Research has propelled Douglas Dynamics into the investor spotlight. The...

Inozyme Pharma Inc Stock

Inozyme Pharma Acquisition Finalized: Strategic Focus Shifts to Clinical Development

September 4, 2025
National Healthcare Stock

National Healthcare Stock: Technical Battle Precedes Potential Upswing

September 4, 2025
Procter & Gamble Stock

Procter & Gamble Navigates a Costly Tariff Landscape

September 4, 2025
PetIQ Stock

Legal Challenges Emerge for PetIQ Following Its Transition to Private Ownership

September 4, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Recent News

  • Douglas Dynamics Stock Surges on Upgraded Forecasts and Record Performance September 4, 2025
  • Inozyme Pharma Acquisition Finalized: Strategic Focus Shifts to Clinical Development September 4, 2025
  • National Healthcare Stock: Technical Battle Precedes Potential Upswing September 4, 2025

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

© 2024 Stocks Today

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com